Myxoedema revealed by simvastatin induced myopathy.
作者信息
al-Jubouri M A, Briston P G, Sinclair D, Chinn R H, Young R M
机构信息
Department of Chemical Pathology, Queen Alexandra Hospital, Cosham, Portsmouth.
出版信息
BMJ. 1994 Feb 26;308(6928):588. doi: 10.1136/bmj.308.6928.588.
Abstract
摘要
相似文献
1
Myxoedema revealed by simvastatin induced myopathy.辛伐他汀诱发的肌病导致的黏液性水肿
BMJ. 1994 Feb 26;308(6928):588. doi: 10.1136/bmj.308.6928.588.
2
Pravastatin and simvastatin for hypercholesterolemia.
Med Lett Drugs Ther. 1991 Mar 8;33(839):18-20.
3
Muscle side effects associated with simvastatin therapy.与辛伐他汀治疗相关的肌肉副作用。
Med J Aust. 1990 Nov 5;153(9):562-3. doi: 10.5694/j.1326-5377.1990.tb126217.x.
4
Simvastatin-induced myopathy in a patient treated for hypercholesterolemia. Morphological aspects.
Pol J Pathol. 1997;48(1):69-74.
5
An overview: long-term tolerability of lovastatin and simvastatin.
Zhonghua Yi Xue Za Zhi (Taipei). 1992 Feb;49(2):138-9.
6
Long-term clinical tolerance of lovastatin and simvastatin.
Cardiology. 1990;77 Suppl 4:58-65. doi: 10.1159/000174684.
7
Polymyositis associated with simvastatin.
Lancet. 1997 May 31;349(9065):1600-1. doi: 10.1016/S0140-6736(05)61628-5.
8
Myopathy secondary to simvastatin in a type 2 diabetic patient.一名2型糖尿病患者继发于辛伐他汀的肌病
J Assoc Physicians India. 2002 Mar;50:439-40.
9
[A new case of simvastatin-induced acute pancreatitis].
Gastroenterol Clin Biol. 1991;15(12):986-7.
10
[Simvastatin-induced hepatitis].
Gastroenterol Clin Biol. 1992;16(1):101.
引用本文的文献
1
Is Kidney Stone Associated with Thyroid Disease? The United States National Health and Nutrition Examination Survey 2007-2018.肾结石与甲状腺疾病有关吗？美国 2007-2018 年国家健康和营养调查。
Endocr Metab Immune Disord Drug Targets. 2024;24(11):1323-1334. doi: 10.2174/0118715303268738231129093935.
2
The evaluation of atorvastatin as an adjunct to fluconazole for the anti-fungal prophylaxis in acute myeloid leukemia: a multicenter, triple-blinded, randomized clinical trial.阿托伐他汀作为氟康唑辅助用药用于急性髓系白血病抗真菌预防的评估：一项多中心、三盲、随机临床试验。
Naunyn Schmiedebergs Arch Pharmacol. 2024 Jun;397(6):4355-4364. doi: 10.1007/s00210-023-02892-w. Epub 2023 Dec 14.
3
Case report: Rhabdomyolysis and kidney injury in a statin-treated hypothyroid patient-kill two birds with one stone.病例报告：他汀类药物治疗的甲状腺功能减退患者发生横纹肌溶解和肾损伤——一石二鸟。 （此译文根据文本字面意思翻译，但从医学角度来说，“一石二鸟”在此语境不太符合准确含义，推测原文可能想表达的是类似“一种情况引发了两种不良后果”之类的意思，具体准确理解需结合更完整的医学背景。） 括号内为补充说明，非翻译内容。 仅按照要求翻译为：病例报告：他汀类药物治疗的甲状腺功能减退患者发生横纹肌溶解和肾损伤——一石二鸟。
Front Med (Lausanne). 2022 Nov 10;9:1046330. doi: 10.3389/fmed.2022.1046330. eCollection 2022.
4
Statin-Associated Myopathy: Emphasis on Mechanisms and Targeted Therapy.他汀类药物相关肌病：重点关注发病机制与靶向治疗。
Int J Mol Sci. 2021 Oct 28;22(21):11687. doi: 10.3390/ijms222111687.
5
[Diagnostics and treatment of statin-associated muscle symptoms].[他汀类药物相关肌肉症状的诊断与治疗]
Internist (Berl). 2021 Aug;62(8):827-840. doi: 10.1007/s00108-021-01059-0. Epub 2021 Jun 18.
6
Statin-Related Myotoxicity: A Comprehensive Review of Pharmacokinetic, Pharmacogenomic and Muscle Components.他汀类药物相关的肌毒性：药代动力学、药物基因组学和肌肉成分的综合综述
J Clin Med. 2019 Dec 20;9(1):22. doi: 10.3390/jcm9010022.
7
[Myopathy linked to statins in patients with recently appeared hypothyroidism].[近期出现甲状腺功能减退患者中与他汀类药物相关的肌病]
Aten Primaria. 2005 Oct 15;36(6):348. doi: 10.1157/13079876.
8
[Myopathy linked to statins in a patient with recently appeared hypothyroidism].[近期出现甲状腺功能减退患者中与他汀类药物相关的肌病]
Aten Primaria. 2005 Jul-Aug;36(3):171-2. doi: 10.1157/13077490.
9
[Unnoticed hypothyroidism and myopathy due to lipid-lowering drugs].[降脂药物所致隐匿性甲状腺功能减退症与肌病]
Aten Primaria. 2001 Apr 15;27(6):442-3. doi: 10.1016/s0212-6567(01)78831-2.
10
Hyperlipidaemia and hypothyroidism. Screen patients for hypothyroidism before treatment.高脂血症和甲状腺功能减退症。治疗前对患者进行甲状腺功能减退症筛查。
BMJ. 1994 Apr 2;308(6933):918. doi: 10.1136/bmj.308.6933.918.
本文引用的文献
1
Plasma enzyme activities in primary hypothyroidism.原发性甲状腺功能减退症中的血浆酶活性。
Clin Chem. 1984 Feb;30(2):323-5.
2
[Rhabdomyolysis under treatment by ciprofibrate in the nephrotic syndrome].[环丙贝特治疗肾病综合征时的横纹肌溶解症]
Therapie. 1987 Mar-Apr;42(2):247-8.
3
Myolysis and acute renal failure in a heart-transplant recipient receiving lovastatin.
N Engl J Med. 1988 Jan 7;318(1):46-7. doi: 10.1056/NEJM198801073180110.
4
Nicotinic acid-associated myopathy: a report of three cases.烟酸相关性肌病：三例报告
Am J Med. 1989 Apr;86(4):481-3. doi: 10.1016/0002-9343(89)90352-5.
5
[Toxic myopathy due to hypolipemic agents].[降血脂药物所致中毒性肌病]
Therapie. 1990 Jul-Aug;45(4):360.
6
[Does hypothyroidism potentialize muscular toxicity of fibrates?].甲状腺功能减退会增强贝特类药物的肌肉毒性吗？
Rev Med Interne. 1990 Jul-Aug;11(4):336. doi: 10.1016/s0248-8663(05)80871-9.
7
The incidence of asymptomatic hypothyroidism in new referrals to a hospital lipid clinic.一家医院血脂门诊新转诊患者中无症状甲状腺功能减退症的发病率。
Ann Clin Biochem. 1991 Sep;28 ( Pt 5):509-11. doi: 10.1177/000456329102800515.
8
Clofibrate-induced muscle damage in patients with chronic renal failure.氯贝丁酯诱导的慢性肾衰竭患者肌肉损伤
Lancet. 1975 Dec 27;2(7948):1279-82. doi: 10.1016/s0140-6736(75)90613-3.
Zotero 插件